Swap 2026

swap 2026

None Rebalancing
EUR
Moderate Risk
19.0yr backtest

Performance Summary

Total Return+1811.86%
Annualized Return+16.82%
Volatility+16.73%
Sharpe Ratio0.89
Max Drawdown+44.44%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Global equity portfolio with a strong healthcare focus, anchored by a multi-asset core fund and leading pharmaceutical stocks for targeted growth.
AssetTypeAllocationTER
LU1038809395
Flossbach von Storch - Multiple Opportunities II RT • LU1038809395
FUND
58.9%1.66%
LLY.XETRA
Eli Lilly and Company • US5324571083
STOCK
21.5%0%
LU0171307068
BlackRock Global Funds - World Healthscience Fund A2 • LU0171307068
FUND
13.0%1.81%
NOV.XETRA
Novo Nordisk A/S • DK0062498333
STOCK
6.6%-
Total100.0%1.21%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €191,185.94
Histogram of Monthly Returns
The portfolio had a positive return during 151 of the 229 months (66%)
Monthly Returns Heatmap
Best month: +16.9% • Worst month: -15.2% • Best year: 2021 (+53.0%) • Worst year: 2008 (-16.2%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.9%-6.6%-7.6%+2.4%+14.4%+10.3%-4.4%+0.2%+1.1%+6.0%--+13.5%
2025+3.3%+7.2%-15.2%+0.3%-8.7%-1.1%-6.7%-0.0%-1.1%+9.6%+16.0%-0.1%-0.3%
2024+10.9%+9.6%+6.6%-0.7%+3.7%+9.7%-9.8%+8.7%-9.8%-1.3%-2.0%-7.0%+16.5%
2023-3.1%-0.6%+7.4%+6.7%+4.3%+2.4%-1.8%+16.9%+0.0%+2.7%+3.6%-0.7%+43.1%
2022-8.8%+1.7%+11.3%+5.4%-1.7%+2.7%+6.0%-5.1%+1.8%+7.2%+1.5%+0.8%+23.4%
2021+7.0%-0.1%+0.8%+0.5%+5.1%+9.3%+5.5%+5.7%-4.1%+8.2%+0.5%+5.9%+53.0%
2020+4.5%-5.8%+2.9%+8.4%-0.9%+1.6%-4.2%+1.0%+1.9%-5.6%+4.4%+4.3%+12.0%
2019+4.5%+4.9%+5.2%-3.9%-1.4%+1.3%+0.4%+4.4%+0.7%+0.9%+3.7%+3.9%+27.0%
2018-0.9%-2.7%+11.4%+2.0%+4.0%-0.9%+6.8%+2.4%-0.2%-1.2%+4.4%-4.8%+21.0%
2017-0.5%+6.0%+0.3%+0.6%-0.4%+0.1%-2.2%+1.6%+2.7%+1.8%+0.5%+1.1%+11.9%
2016-7.3%-0.2%+0.2%+1.9%+2.0%+0.2%+4.7%-4.7%-2.5%-4.3%-1.1%+4.9%-6.9%
2015+8.4%+2.3%+7.6%-1.7%+3.2%-1.7%+4.2%-5.4%-4.0%+6.1%+3.5%+0.1%+23.7%
2014+2.1%+7.1%-1.1%-0.0%+0.7%+3.2%+0.8%+2.5%+4.3%+0.1%+2.7%+1.7%+26.7%
2013+5.2%+2.3%+3.3%-0.0%-0.5%-4.2%+3.7%-1.3%-0.1%+0.1%+2.5%-0.1%+11.2%
2012+1.7%+3.8%+2.7%+1.5%-0.6%+1.0%+6.4%+0.9%+0.7%-0.7%+1.9%-0.6%+20.1%
2011-2.7%+3.5%-0.6%+0.8%+2.9%-2.0%+1.6%-0.7%-0.3%+1.5%+2.5%+4.9%+12.0%
2010+2.9%+1.9%+4.8%+1.0%-1.0%+1.2%-3.3%+1.7%+2.6%+1.9%+1.6%+4.4%+21.1%
2009+3.4%-8.8%+1.9%+6.3%+1.6%+3.7%+5.1%+3.2%+1.9%+1.8%+2.9%+2.7%+28.0%
2008-5.4%+1.6%-3.1%+1.7%+3.8%-4.8%+0.0%+3.0%-11.0%-5.3%+0.1%+3.2%-16.2%
2007----------0.8%-2.6%+1.9%-1.6%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +44.44% • The longest drawdown period lasted for 2 years and 3 months and was between June 2024 and October 2026. It reached a trough of -44.4%.
When could this portfolio get you to financial independence?

Swap 2026 returned +16.82% a year over the 19 years above. Run those same monthly returns forward through 10,000 simulated paths, with your own savings and target retirement age, to see when they could reach your FIRE number.

Detailed Metrics

Returns
Total Return
+1811.86%
Annualized Return
+16.82%
Avg Monthly Return
+1.40%
Risk
Volatility (Annual)
+16.73%
Max Drawdown
+44.44%
Positive Months
66%
Average Drawdown
-6.7%
Risk-Adjusted
Sharpe Ratio
0.89
Risk-free rate: 2.0%
Sortino Ratio
0.87
Downside risk adjusted
Return/Volatility
1.01
Calmar Ratio
0.38
Return/Max Drawdown
Ulcer Index
9.95
Drawdown depth & duration
Martin Ratio
0.01
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€191,185.94
Backtest Period
2007-10-23 to 2026-10-16
19.0 years
Rebalancing
none
Base Currency
EUR